Drug Safety teams across the globe now have access to the latest solutions to gain efficiencies and optimize costs via a new strategic partnership between ArisGlobal and Nextrove
Boston, Massachusetts, USA – February 22, 2024 – ArisGlobal, a leading innovative life sciences technology company and creator of LifeSphere®, has announced a new strategic partnership with Nextrove, an implementation, systems integration, and data migration specialist within life sciences. The partnership creates a larger pool of expert resources available to pharmaceutical organization implement next-generation LifeSphere solutions.
Customers across North America, Europe, United Kingdom (UK), India, China, South Korea, and Japan can leverage LifeSphere products via Nextrove implementation and expertise. The most recent client collaborations include KeyMed Biopharmaceuticals (China), and other pharmaceutical companies from the US, Europe, and Japan. Nextrove will help deliver ArisGlobal’s entire end-to-end LifeSphere Safety platform.
Together, ArisGlobal and Nextrove are able to deliver rapid and accelerated project implementations on-time and to-plan. The integrated team leverages proven, automated, and pre-developed tools with a highly standardized project lifecycle to execute projects with the highest quality and to-budget assurance.
Raj Hattarki, Senior Vice President, Head of Consulting at ArisGlobal, said:
“This partnership marks a significant step for ArisGlobal as it makes it even easier for life sciences organizations worldwide to adopt our sophisticated SaaS platform and modernize their Pharmacovigilance (PV) processes. As frontrunners in embracing state-of-the-art technologies like AI/ML in Drug Safety systems, teaming up with a partner like Nextrove is crucial. Nextrove brings complementary skills in modernizing PV operations and transitioning to advanced systems like LifeSphere Safety. This collaboration is set to speed up implementation process and ensure timely delivery, aligning with the high quality and service expectations our clients deserve.”
Anjani Jha, Chief Executive Officer of Nextrove, said: “We are delighted at this opportunity to bring LifeSphere to pharma and biotech companies globally. This powerful platform is built on a completely new, cutting-edge technology architecture featuring the latest automation and cognitive computing technologies – something companies are crying out for more than ever. We’re excited at the prospect of streamlining companies’ access to these capabilities, whatever their current technology set-up.”
About ArisGlobal
ArisGlobal, the creator of LifeSphere, is a market leader in global patient treatment technology solutions that is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan, and China. For more updates, follow ArisGlobal on LinkedIn. www.arisglobal.com.
About Nextrove
Nextrove, headquartered in New Jersey, USA, is a global professional services firm exclusively serving pharmaceutical and biotech organizations. Its professionals have extensive experience of performing complex integrations between PV, clinical, regulatory, and product quality databases. The company also provides a comprehensive range of tools and accelerators to aid data migrations and analysis of data issues, and fast-track new platform/solution implementations.
Download ArisGlobal’s 2024 Industry Report 
